Clin2
NCT07367542Possibly a fitNot yet recruiting

Esketamine for emotional distress during breast cancer surgery

DepressionAnxietyS-ketamineBreast Cancer

Treatments studied

Part of Cancer, Mental health, Skin clinical trials.

This trial tests whether a medicine called esketamine, given during breast cancer surgery, can help reduce negative emotions like anxiety or depression before and after the operation. It may help you feel more emotionally stable during your treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
218 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are scheduled for breast cancer surgery at the study hospital.
  • Your surgery is expected to last more than 90 minutes.
  • You are in generally good health apart from breast cancer and are classified as ASA I-III (your anesthesiologist will confirm).
  • You are not currently taking antipsychotics, antidepressants, or glucocorticoids, and you do not have a history of alcohol or drug abuse.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07374198Not yet recruiting
Esketamine during breast cancer surgery to reduce depression

This study tests whether giving a medication called esketamine during breast cancer surgery can help reduce feelings of depression and anxiety after the operation. If you are having breast cancer surgery and have been feeling down, this treatment might support your emotional well-being during recovery.

NCT07374211Not yet recruiting
Esketamine for breast cancer surgery patients with severe depression

This trial tests whether a medication called esketamine, given during breast cancer surgery, can help reduce feelings of depression and anxiety after the operation. It is for women who are already experiencing severe depressive symptoms before surgery.

NCT06665568Not yet recruiting· Early Phase 1
Ketamine nasal spray for depression and anxiety in advanced cancer

This study tests whether a ketamine nasal spray can help reduce depression and anxiety in people with advanced cancer. It also looks at how caregivers are affected. If you are living with progressive cancer and feeling down or anxious, this treatment might offer some relief.

Zurich, Canton of Zurich
NCT07247968Recruiting· Early Phase 1
Esketamine with ECT for severe depression in teens

This study tests whether adding a low dose of esketamine (a type of anesthesia) to modified electroconvulsive therapy (ECT) helps treat severe depression in teenagers. It aims to see if this combination works better and is safer than ECT alone.

Chongqing
NCT06085937Recruiting· Phase 1
Ketamine for suicidal patients in the ER

This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.

Kansas City, Kansas
NCT07523334Not yet recruiting· Phase 4
Esketamine for preventing confusion after surgery in older adults

This study tests whether a medicine called esketamine, given during and after surgery, can lower the chance of confusion or memory problems in older adults. It is for people aged 65 to 90 having non-cardiac surgery that lasts at least 2 hours.

Beijing, Beijing Municipality

Hear when a new Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.